GORTEC (Groupe d'Oncologie Radiothérapie Tête Et Cou or Head and Neck Oncology and Radiotherapy Group) was created in 1999 by five founding centers (Clermont-Ferrand, Nancy, Nantes, Tours and Villejuif) with the aim of coordinating clinical and/or laboratory studies in the field of cervicofacial oncology. GORTEC studies are open to all centers wishing to participate. However, a quality control of the records of patients included in these trials is routinely performed by outside experts.
A few figures
Investigators
Cancer treatment centers
Member physicians
Employees
- Multidisciplinary network of around 500 Investigators: Surgeons, Radiotherapists, Oncologists, Radiologists.
- Network of >+ than 100 cancer treatment centers in France, Switzerland, Belgium, Germany, Spain, Greece and Poland
- National and international clinical trials: Phase III (predominantly), Phase II & Phase I.
- Founding member of and driving force behind Intergroupe ORL (ENT intergoup), labeled by INCa (Institut National du Cancer or French National Cancer Institute) since 2012
- Over 225 members (Physicians)
- Approximately 40 employees
- Organization of biannual scientific meetings (Approximately 180 participants)
Management board
Dr Yoann Pointreau
Chairman
In parallel with the Management Board, the association has set up a Strategic and Scientific Committee composed of some twenty members, who are very active in terms of patient recruitment for clinical studies.